This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Tania Jain, MBBS: ...

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Tania Jain, MBBS: ...

Myelofibrosis-related anemia is different than anemia experienced by patients without a cancer diagnosis, a research nurse explained. Anemia is a common and potentially dangerous condition that can ...

Myelofibrosis remains a rare disease, even though recent attention to the condition might suggest otherwise. "I suspect that the incidence is actually higher than what we originally thought, not only ...

The 2026 heme-onc pipeline accelerates with Karyopharm Therapeutics announcing a label expansion for selinexor following a late-stage myelofibrosis win, while the GBM AGILE trial definitively closes ...

Moshe Talpaz, MD: Myelofibrosis has a very heterogeneous course and a very heterogeneous course of outcome. Patients can live anywhere from 1 year to 15 years or longer. And it’s important to ...

Allogeneic stem cell transplant is the only treatment that has the potential to cure myelofibrosis. "It's very important to include stem cell transplant in 2024 -- and beyond -- in every conversation, ...

A post hoc analysis of the phase 3b JUMP trial supports the real-world use of ruxolitinib with anemia supportive care to maintain dosing and clinical outcomes in patients with myelofibrosis, offering ...

Indications span MF and PV in adults, plus acute/chronic GVHD in patients ≥12 years, positioning XR as a once-daily ...

LONDON--(BUSINESS WIRE)--GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved Ojjaara (momelotinib) for the treatment of intermediate or high-risk ...

NEWTON, Mass., Sept. 10, 2025 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that it has ...